DrugPatentWatch was used in a recent research study on branded drug sales following generic entry. In this paper, authors Jeffrey Fujimoto, Daniel M Tien, Sophie Snyder, Jeppe A Hertz, and…
The post The effect of patent expiration on sales of branded c…
DrugPatentWatch serves companies across the drug development-delivery sector. A common request among drug manufacturers, payers, and suppliers alike is anticipation of which branded drugs will face generic competition, and when…
The post Customer Succe…
Customer Success: Will a generic version of a drug launch? And when? Read Post »
Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry, from new formulations of drugs, or from competition from novel…
The post Customer Success: API and CDMO Business Dev…
Customer Success: API and CDMO Business Development Read Post »
Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry, from new formulations of drugs, or from competition from novel…
The post Customer Success: API and CDMO Business Dev…
Customer Success: API and CDMO Business Development Read Post »
DrugPatentWatch has deep resources to support patent prosecution and patent litigation, but it is also used by law firms for business development. Find weak claims One of the first tweaks…
The post Customer Success: Law Firm Business Development appear…
DrugPatentWatch has deep resources to support patent prosecution and patent litigation, but it is also used by law firms for business development. Find weak claims One of the first tweaks…
The post Customer Success: Law Firm Business Development appear…
The launch of a new product can be a daunting task. The main reason this happens is that no matter how many times your company has managed to enter new…
The post Mistakes to Be Avoided When Preparing a Drug Launch appeared first on DrugPatentWatch – Ma…
Mistakes to Be Avoided When Preparing a Drug Launch Read Post »
This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under a creative commons license. Abstract The key events in the…
The post Development of the generic drug industry in the US afte…
Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984 Read Post »
DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants well before they launch. CDMOs, equipment manufacturers, regulatory consultants, and…
The post Customer …
Customer Success: How do we identify generic entrants before they get FDA approval? Read Post »
The latest Swiss Biotech annual report focuses on the theme of shaping change. Change is a theme DrugPatentWatch is very familiar with — whether it is a matter of tracking…
The post DrugPatentWatch Headlines Swissbiotech Annual Report appeared first on…
DrugPatentWatch Headlines Swissbiotech Annual Report Read Post »